pf-03654746
Showing 1 - 5 of 5
Tourette's Syndrome Trial in Manhasset (PF-03654746, Placebo)
Withdrawn
- Tourette's Syndrome
- PF-03654746
- Placebo
-
Manhasset, New YorkPfizer Investigational Site
Mar 28, 2019
ADHD Trial in United States (PF-03654746, Placebo capsules)
Completed
- Attention Deficit Hyperactivity Disorder
- PF-03654746
- Placebo capsules
-
Lafayette, California
- +6 more
Jan 22, 2016
Allergic Rhinitis Trial in Omaha (Placebo, Allegra, Allegra-D)
Completed
- Allergic Rhinitis
- Placebo
- +3 more
-
Omaha, NebraskaPfizer Investigational Site
Mar 10, 2014
Excessive Daytime Sleepiness, Narcolepsy Trial in United States (Placebo, PF-03654746)
Completed
- Excessive Daytime Sleepiness
- Narcolepsy
- Placebo
- PF-03654746
-
Phoenix, Arizona
- +20 more
Apr 8, 2014